Constipation Treatment Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||921897|
|出版日期||內容資訊||英文 111 Pages
|全球便秘治療市場:成長，趨勢，及預測(2020年∼2025年) Constipation Treatment Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年01月01日||內容資訊: 英文 111 Pages||
The constipation treatment market will show rapid growth due to factors such as increasing geriatric population and changing dietary habits, high prevalence of IBS-C, OIC and chronic constipation and the development of the latest drugs and treatment procedures.
The irritable bowel syndrome (IBS) is found to be a chronic, recurring, and remitting functional disorder of the gastrointestinal tract that causes abdominal pain, distention, and changes in bowel habits. Irritable bowel syndrome (IBS) is found affecting up to 7%-18% of the population worldwide and therefore its prevalence is increasing that is driving the overall market. Although there are several drugs for IBS in the market that are effective and approved treatments for one or more of the symptoms for various IBS subtypes are needed.
There are also newer pharmacological treatments being available for constipation that is superior to placebo in relieving constipation. But there is no single approach to treat IBS-C. Often, people use a mix of therapies to get relief. They can include changes in diet, exercise, stress management, and medication. Hence all these factors are associated with the increase in the overall growth of the market.
As per the scope of the report, constipation is a common medical condition that affects the normal life of an individual, and prolonged constipation could be a symptom of more severe diseases and disorders. It is estimated to affect every one individual once in a lifetime. Constipation may be occasional which lasts for a few weeks or maybe chronic which lasts for a longer period and is recurrent. Therefore it may be associated with other conditions such as irritable bowel syndrome or opioid consumption also.
Laxatives are Expected to Dominate the Constipation Market During the Forecast Period
On the basis of therapeutic option, the global market for constipation treatment is segmented into laxatives, peripherally acting mu-opioid receptor antagonists, chloride channel activators, GC-C agonists, and 5-HT4 receptor agonists. And the laxatives are a type of medicine that can treat constipation. They're often used if lifestyle changes, such as increasing the amount of fiber in your diet, drinking plenty of fluid and taking regular exercise, have not helped. Therefore over the course of the forecast period, the laxatives segment is anticipated to be most promising and dominate the market share. Affordability for the masses owing to low cost and wide availability are two key factors leading to the prosperity of this laxatives segment.
North America is Found to be the Largest Growing Region in the Constipation Market
North America is found to be the largest growing region of the market, and it is mainly driven due to the increasing prevalence of chronic constipation and growing investment in healthcare. Furthermore, the U.S. holds the largest market share in the North America region owing to factors such as the presence of a large number of market players manufacturing medications for constipation. And Canada is expected to show the fastest growth in North America which is driven by the overall increasing demand for diagnostic and treatment methods.
Asia Pacific is also expected to be the fastest-growing market whose growth is attributed to a huge demand for diagnostic tests and increasing focus on early diagnosis and treatment of GI diseases.
The heavy investments are being made by manufacturers towards the development of novel therapeutic drugs for constipation and are expected to fortify the global market. These ardent efforts by the manufacturers of therapeutic drugs for the treatment of constipation have aided the growth of the global market.